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Results

Background
• Therapy with immune checkpoint inhibitors (ICIs) has
changed the treatment landscape of Non-small Cell
Lung Cancer (NSCLC), yet only ~20-40% of patients
benefit from it [1].

344SQ-HELLO and 344SQ-NINJA cells expressed HELLO and NINJA neoantigens
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• Tertiary Lymphoid structures (TLS) have been shown
to be associated with response to ICIs in cancers [2].
• TLS formation and maturation correlate with higher
intratumoral T/B cell function, suggesting that
understanding the mechanisms by which T/B cell
interact within TLS in NSCLC tumors could improve
the efficacy of ICI treatment [3].
• NINJA- and HELLO antigen-expressing cancer cells
may drive tumor-specific T, B and TFH cell
responses which allow to study their interaction in
tumors [4].

Hypothesis
We hypothesized that HELLO and NINJA antigenexpressing NSCLC cells will be useful models to study
T/B cell interaction within the tumor microenvironment.
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Figure 2. (A) Images of 344SQ-LentiT, -HELLO and –NINJA cells showing
expression of HELLO (red) or NINJA (green) neoantigens, using 20X
magnification. Visual representation of HELLO (B) and NINJA (C) models which
were transfected into 344SQ cells.
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Tumors and dLNs removal
•Flow Cytometry

Figure 5. The frequency of CD4 TFH cells (A) and
Tregs (B) in tumors was measured by flow cytometry.

Figure 6. The frequency of activated CD4+ (A) and CD8+
(B) T cells in dLN was measured by flow cytometry.

Tumors of HELLO mice exhibited numerically higher frequencies of GC B cells in dLNs
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Figure 7. The frequency of CD19+ (A), CD20+ (B), GC B cells (C) and plasma cells (D) in dLNs was measured
by flow cytometry.
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Figure 1. Diagram representing the experimental design.
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NINJA tumors exhibited the greatest tumor growth reduction compared to HELLO and LentiT tumors
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Methods
Cell transfection

Greater infiltration of CD4 TFH cells was
observed in NINJA tumors whereas Treg
infiltration was increased in HELLO tumors

Figure 3. Tumor growth was measured from day 0 to day 23. On
day 24 mice were euthanized and tumors were harvested. Tumor
growth curves were graphed by using the average of each group
(A) and each group (LentiT, HELLO or NINJA) individually (B). (C)
The fold change in tumor volume was determined for each mouse
from day 4 to day 23 using the formula: (tumor volume on day 23 day 4) / day 4. (D) Representative images of harvested tumors on
day 24. (E) Comparison of final tumor volume by average among
groups.

• Tumor growth was significantly decreased in the 344SQ-NINJA model, compared
to 344SQ-HELLO and 344SQ-LentiT models.
• Infiltration of antigen-specific CD4, CD8 T cells and cytotoxic CD8 T cells was
increased in NINJA tumors compared to Lenti-T tumors.
• NINJA tumors presented higher infiltration of CD4 TFH cells, which may suggest a
role of this subpopulation in the antitumor response.
• HELLO tumors presented higher infiltration of Tregs, which may play a role in the
reduced antitumor effect of HELLO vs NINJA antigens.
• The higher amount of activated Tet+ CD8+ T cells in dLNs of HELLO vs that of
NINJA and LentiT tumor-bearing mice suggests potential distinct tumor antigenspecific immune responses in these models.

344SQ cells were transfected with a lentivirus containing
Significant increase of activated Tetramer+ CD4+ and CD8+ T cells, and cytotoxic CD8 T cells in NINJA tumors
HELLO (mSarlet-HEL-GP33-43/FLAG/GP6180) or NINJA
(GFP-GP33-43 /FLAG/GP61–80) transcript.
A CD3+ cells
C CD4+ Tet+ T cells
B CD4+ T cells
F CD8+ Tet+ T cells
D CD4+ Tet+ ICOS+ T cells E CD8+ T cells
G CD8+ Tet+ ICOS+ T cells H CD8+ Tet+ GZMB+ T cells
EVOS microscope was used to evaluate HELLO and
• In vitro functional study of CD4 and CD8 T cells and B cells isolated from the HELLO,
NINJA expression.
NINJA and LentiT tumors and dLNs.
129sv mice were injected subcutaneously in the flank with
a 100uL preparation of 5x10^5 cells of the corresponding
• Evaluate T and B cell infiltration in HELLO and NINJA tumors by IHC.
group suspended in PBS and Matrigel (1:1).
• In vivo efficacy study of ICI therapy in orthotopic murine models of 344SQ NSCLC
The tumor size was measured using a digital caliper 3
expressing NINJA and HELLO antigens.
days per week up to day 23. Tumor volume was calculated
using the formula: (length x width ^2)/2.
On day 24 mice were euthanized. Tumors, draining lymph
1. Cascone T., et al. Cold Spring Harbor Perspectives Med. 2022.
nodes (dLNs) and spleens were harvested.
2. Wang L. and Wargo J. Nature. 2020
Figure 4. Flow cytometry of tumors was performed using a T cell panel for determining the frequency of CD3+ cells (A), CD4+ T cells (B) and GP66-specific
Flow cytometry analysis was performed on tumors and
3. Sautès-Fridman C., et al. Nature Reviews Cancer. 2019
CD4+ T cells (C) in tumors. Activation of GP66-specific CD4+ T cells (D) was measured by ICOS expression. Frequency of CD8+ T cells (E), GP33-specific
dLNs.
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CD8+ T cells (F), activated GP33-specific CD8+ T cells (G) and cytotoxic GP33-specific CD8+ T cells (H) in tumors.
Results were graphed using Prism 9 and One-way
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ANOVA test was performed for statistical purposes.
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